My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking
Future Enterprises standalone net profit rises 615.37% in the June 2016 quarter

Future Enterprises standalone net profit rises 615.37% in the June 2016 quarter

Sep 14,2016

Net profit of Future Enterprises rose 615.37% to Rs 315.48 crore in the quarter ended June 2016 as against Rs 44.10 crore during the previous quarter ended June 2015. Sales declined 67.64% to Rs 921.19 crore in the quarter ended June 2016 as against Rs 2846.84 crore during the previous quarter ended June 2015.

ParticularsQuarter Ended
n++Jun. 2016Jun. 2015% Var.
Sales921.192846.84-68
OPM %24.969.91-
PBDT295.07184.1360
PBT142.3249.92185
NP315.4844.10615

Powered by Capital Market - Live News

ACI Infocom standalone net profit rises 150.00% in the September 2016 quarter
Dec 19,2016

Net profit of ACI Infocom rose 150.00% to Rs 0.05 crore in the quarter ended September 2016 as against Rs 0.02 crore during the previous quarter ended September 2015. Sales rose 1379.17% to Rs 3.55 crore in the quarter ended September 2016 as against Rs 0.24 crore during the previous quarter ended September 2015.

ParticularsQuarter Endedn++Sep. 2016Sep. 2015% Var. Sales3.550.24 1379 OPM %-2.25-25.00 - PBDT0.070.02 250 PBT0.070.02 250 NP0.050.02 150

Powered by Capital Market - Live News

City Online Services standalone net profit rises 2000.00% in the September 2016 quarter
Dec 19,2016

Net profit of City Online Services rose 2000.00% to Rs 0.21 crore in the quarter ended September 2016 as against Rs 0.01 crore during the previous quarter ended September 2015. Sales rose 55.18% to Rs 4.64 crore in the quarter ended September 2016 as against Rs 2.99 crore during the previous quarter ended September 2015.

ParticularsQuarter Endedn++Sep. 2016Sep. 2015% Var. Sales4.642.99 55 OPM %7.113.01 - PBDT0.270.14 93 PBT0.210.01 2000 NP0.210.01 2000

Powered by Capital Market - Live News

Innoventive Industries reports standalone net loss of Rs 55.22 crore in the September 2016 quarter
Dec 19,2016

Net Loss of Innoventive Industries reported to Rs 55.22 crore in the quarter ended September 2016 as against net loss of Rs 43.99 crore during the previous quarter ended September 2015. Sales rose 6.61% to Rs 95.01 crore in the quarter ended September 2016 as against Rs 89.12 crore during the previous quarter ended September 2015.

ParticularsQuarter Endedn++Sep. 2016Sep. 2015% Var. Sales95.0189.12 7 OPM %-5.767.27 - PBDT-39.34-28.13 -40 PBT-55.22-43.99 -26 NP-55.22-43.99 -26

Powered by Capital Market - Live News

Adi Rasayan reports standalone net profit of Rs 0.04 crore in the September 2016 quarter
Dec 19,2016

Net profit of Adi Rasayan reported to Rs 0.04 crore in the quarter ended September 2016 as against net loss of Rs 0.02 crore during the previous quarter ended September 2015. There were no Sales reported in the quarter ended September 2016 and during the previous quarter ended September 2015.

Powered by Capital Market - Live News

REI Agro reports standalone net loss of Rs 66.30 crore in the September 2016 quarter
Dec 19,2016

Net Loss of REI Agro reported to Rs 66.30 crore in the quarter ended September 2016 as against net loss of Rs 131.48 crore during the previous quarter ended September 2015. Sales declined 83.48% to Rs 17.61 crore in the quarter ended September 2016 as against Rs 106.62 crore during the previous quarter ended September 2015.

ParticularsQuarter Endedn++Sep. 2016Sep. 2015% Var. Sales17.61106.62 -83 OPM %-197.50-39.84 - PBDT-40.26-105.15 62 PBT-66.30-131.48 50 NP-66.30-131.48 50

Powered by Capital Market - Live News

Opto Circuits (India) and its subsidiaries secure order worth Rs 91 crore
Dec 19,2016

Opto Circuits (India) and its subsidiaries have received an order worth Rs 91 crore from Philips Health Care for various products manufactured by Opto Group of Companies.

Powered by Capital Market - Live News

Granules Indian provides update on USFDA inspection of Granules OmniChems Vizag facility
Dec 19,2016

Granules Indian announced that Granules OmniChem facility (a 50:50 joint venture company of Granules India and Ajinimoto OmniChem) located at Vizag, Andhra Pradesh completed its first inspection by USFDA with seven observation. Granules OmniChem will respond to these observations within stipulated time period. This facility currently manufactures API intermediates.

Powered by Capital Market - Live News

Oil India fixes record date for bonus issue
Dec 19,2016

Oil India has fixed 13 January 2017 as the Record Date for the purpose of ascertaining the eligibility of shareholders for issuance of Bonus shares in the ratio of 1:3 (i.e. 1(one) bonus equity shares of Rs .10/- each for every 3 (three) existing fully paid up equity share of Rs 10/- each, subject to the approval of shareholders.

Powered by Capital Market - Live News

PTL Enterprises gets High Court approval for scheme of demerger
Dec 19,2016

PTL Enterprises announced that the scheme of demerger of Medicare and Healthcare Undertaking of PTL Enterprises into Artemis Global Life Sciences (formerly known as PTL Projects ) was sanctioned by the Honble High Court of Kerala on 16 December 2016.

The Company is yet to receive the certified copy of the order from the Honble High Court of Kerala for the same.

Powered by Capital Market - Live News

City Union Bank opens new branch at Kuniamuthur in Coimbatore
Dec 19,2016

City Union Bank opened its 527th branch at Kuniamuthur in Coimbatore on 19 December 2016.

Powered by Capital Market - Live News

Cipla receives ANDA approval for Fenofibrate Tablets
Dec 19,2016

Cipla has received final approval for its Abbreviated New Drug Application (ANDA) for Fenofibrate Tablets USP 48mg and 145mg, from the United States Food and Drug Administration (USFDA).

Fenofibrate Tablets, USP 48mg and 145mg, are AB-rated generic equivalents of AbbVies Tricorn++ Tablets and are indicated as adjunctive therapy to diet to reduce elevated low-density lipoproteincholesterol (LDL-C), total cholesterol (Total-C), Triglycerides and apolipoprotein B(Apo B), and to increase high-density lipoprotein cholesterol (HDL-C) in adult patients with primary hypercholesterolemia or mixed dyslipidemia.

Powered by Capital Market - Live News

Engineers India advances after setting record date for bonus issue
Dec 19,2016

The announcement was made during market hours today, 19 December 2016.

Meanwhile, the S&P BSE Sensex was down 81.36 points or 0.31% at 26,408.20

On the BSE, 2.34 lakh shares were traded on the counter so far as against the average daily volumes of 2 lakh shares in the past one quarter. The stock hit a high of Rs 317.80 in intraday trade so far, which is 52-week high for the counter. The stock hit a low of Rs 307.30 so far during the day. The stock had hit a 52-week low of Rs 143.25 on 17 February 2016. The stock had outperformed the market over the past 30 days till 16 December 2016, rising 14.61% compared with the 1% rise in the Sensex. The scrip also outperformed the market in past one quarter, gaining 19.22% as against Sensexs 7.38% decline.

The large-cap company has equity capital of Rs 168.47 crore. Face value per share is Rs 5.

Engineers India had on 16 November 2016 said that its board has approved 1:1 bonus issue of shares.

Engineers Indias net profit rose 21.42% to Rs 93.75 crore on 22.6% decline in total income to Rs 394.99 crore in Q2 September 2016 over Q2 September 2015.

State-run Engineers India provides engineering consultancy and EPC services, mainly to the oil and gas and petrochemical industries. The company has also diversified into sectors like infrastructure, water and waste management, solar and nuclear power and fertilizers to leverage its strong technical competencies and track record. The government of India holds 59.37% in Engineers India (as per shareholding pattern as on 30 September 2016).

Powered by Capital Market - Live News

Anuh Pharma corrects on profit booking
Dec 19,2016

Meanwhile, the BSE Sensex was down 107.22 points, or 0.40%, to 26,382.34.

On the BSE, so far 31,000 shares were traded in the counter, compared with average daily volumes of 17,114 shares in the past one quarter. The stock had hit a high of Rs 244.45 and a low of Rs 221.75 so far during the day.

The stock hit a 52-week high of Rs 344 on 21 December 2015. The stock hit a 52-week low of Rs 159 on 21 April 2016. The stock had outperformed the market over the past 30 days till 16 December 2016, rising 17.77% compared with the 1% rise in the Sensex. The scrip had also outperformed the market in past one quarter, rising 3.40% as against Sensexs 7.38% decline.

The small-cap company has equity capital of Rs 12.53 crore. Face value per share is Rs 5.

Shares of Anuh Pharma surged 16.54% to settle at Rs 238.55 on Friday, 16 December 2016, after the company announced that French National Agency for Medicines and Health Products Safety (ANSM) considers manufacturing site of the company at MIDC Tarapur in Maharashtra in compliance with principles of good manufacturing practices (GMP) for active substances and has granted European Union good manufacturing practices (EUGMP) certificate for Erythromycin Ethyl Succinate and Pyrazinamide products. ANSM carried out the inspection of the manufacturing site on 16 September 2016.

Separately, Anuh Pharma announced that World Health Organisation (WHO), Geneva, considers the manufacturing site of the company at MIDC Tarapur in Maharashtra in compliance to WHO GMPs for Pyrazinamide APIMF158 and Sulfadoxine APIMF234, active pharmaceutical ingredients. The inspection of the manufacturing site by the WHO was carried out on 16 September 2016.

Both the announcements were made during market hours on Friday, 16 December 2016.

Anuh Pharmas net profit dropped 34.5% to Rs 4.87 crore on 44.2% drop in net sales to Rs 50.07 crore in Q2 September 2016 over Q2 September 2015.

Anuh Pharma manufactures active pharmaceutical ingredients (APIs).

Powered by Capital Market - Live News

GSFC, FACT spurt after caprolactam prices hit 2-year high
Dec 19,2016

Gujarat State Fertilizers & Chemicals (GSFC) (up 9.29% to Rs 95.85) and Fertilizers and Chemicals Travancore (FACT) (up 5.42% to Rs 24.30), edged higher.

The S&P BSE Sensex was down 50.03 points, or 0.19% at 26,439.53.

According to media reports, Asian caprolactam hit a 2-year high on Thursday, 15 December 2016, with the CFR Far East Asia marker assessed by S&P Global Platts at $1,830 per metric tonne. The last time the price was at this level was on 18 December 2014, when the Platts CFR Far East Asia marker was assessed at $1,900 a metric tonne.

Caprolactam, a derivative of benzene, is used for manufacturing nylon, tyre-cord, textile filament yarn and engineering plastics.

GSFC and FACT are two major manufacturers of caprolactam in India. GSFC has two caprolactam plants having rated capacities of 20,000 tonnes per annum (TPA) and 50,000 TPA. Meanwhile, FACT has the capacity to produce 50,000 tonnes of caprolactam in a year. FACT exports caprolactam to various countries, including the US.

Powered by Capital Market - Live News

Surya Roshni announces appointment of director
Dec 19,2016

Surya Roshni announced that the Board of Directors of the Company by Circular Resolution has appointed Urmil Agarwal as an Additional Director (Member of Promoter Group and Immediate relative of Promoter) of the Company.

Powered by Capital Market - Live News